Detalhe da pesquisa
1.
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia.
Haematologica
; 106(2): 565-573, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241846
2.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Blood
; 132(16): 1703-1713, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190321
3.
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
Ann Hematol
; 98(8): 1905-1918, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31104089
4.
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
RNA
; 22(10): 1535-49, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492256
5.
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(7): 1095-1101, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389256
6.
Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis.
PLoS Genet
; 10(8): e1004558, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122120
7.
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
Blood
; 123(6): 914-20, 2014 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335498
8.
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.
Blood
; 122(16): 2877-87, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23954893
9.
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
Ann Hematol
; 99(6): 1415-1417, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296913
10.
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia.
Haematologica
; 99(9): 1456-64, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24895338
11.
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Ann Hematol
; 92(3): 315-23, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23233047
12.
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody.
Oncoimmunology
; 12(1): 2255041, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37860278
13.
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
J Med Chem
; 65(2): 1171-1205, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726055
14.
A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
Leukemia
; 36(3): 675-686, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732858
15.
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation.
Blood
; 113(26): 6567-71, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389879
16.
Rationalization of the activity Profile of Pyruvate Kinase Isozyme M2 (PKM2) Inhibitors using 3D QSAR.
Curr Top Med Chem
; 21(25): 2258-2271, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348626
17.
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite.
Cancers (Basel)
; 13(8)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916994
18.
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.
Leukemia
; 35(5): 1301-1316, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948843
19.
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.
Blood Adv
; 5(9): 2294-2304, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929500
20.
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia.
Haematologica
; 100(4): e122-4, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25552704